Skip to main content

Abstract 2496: In silico screeening of therapeutics candidates targeting minimal residual disease in glioblastoma

Publication ,  Conference
Congivaram, H; Tripathi, S; Gomez, M; McCortney, K; Wai, CM; Du, R; Sears, TK; Brat, DJ; Horbinski, CM; Youngblood, MW; Ahrendsen, JT; Sita, T ...
Published in: Cancer Research
April 3, 2026

Duke Scholars

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 3, 2026

Volume

86

Issue

7_Supplement

Start / End Page

2496 / 2496

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Congivaram, H., Tripathi, S., Gomez, M., McCortney, K., Wai, C. M., Du, R., … Heimberger, A. B. (2026). Abstract 2496: In silico screeening of therapeutics candidates targeting minimal residual disease in glioblastoma. In Cancer Research (Vol. 86, pp. 2496–2496). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2026-2496
Congivaram, Harrshavasan, Shashwat Tripathi, Mateo Gomez, Katy McCortney, Ching Man Wai, Ruochen Du, Thomas K. Sears, et al. “Abstract 2496: In silico screeening of therapeutics candidates targeting minimal residual disease in glioblastoma.” In Cancer Research, 86:2496–2496. American Association for Cancer Research (AACR), 2026. https://doi.org/10.1158/1538-7445.am2026-2496.
Congivaram H, Tripathi S, Gomez M, McCortney K, Wai CM, Du R, et al. Abstract 2496: In silico screeening of therapeutics candidates targeting minimal residual disease in glioblastoma. In: Cancer Research. American Association for Cancer Research (AACR); 2026. p. 2496–2496.
Congivaram, Harrshavasan, et al. “Abstract 2496: In silico screeening of therapeutics candidates targeting minimal residual disease in glioblastoma.” Cancer Research, vol. 86, no. 7_Supplement, American Association for Cancer Research (AACR), 2026, pp. 2496–2496. Crossref, doi:10.1158/1538-7445.am2026-2496.
Congivaram H, Tripathi S, Gomez M, McCortney K, Wai CM, Du R, Sears TK, Brat DJ, Horbinski CM, Youngblood MW, Ahrendsen JT, Sonabend AM, Magill ST, Tate MC, Lesniak MS, Sachdev S, Sita T, Kumthekar P, Dixit K, Buerki R, Primdahl D, Khasraw M, de Groot J, Reardon DA, Lukas RV, Stupp R, Heimberger AB. Abstract 2496: In silico screeening of therapeutics candidates targeting minimal residual disease in glioblastoma. Cancer Research. American Association for Cancer Research (AACR); 2026. p. 2496–2496.

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 3, 2026

Volume

86

Issue

7_Supplement

Start / End Page

2496 / 2496

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology